APIDRA
APIDRA
Approved
DIN Number
02279479
Drug Class
Human
Market Date
Oct 1, 2009
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02279479
AIG Number0151630001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AB06 INSULIN GLULISINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
INSULIN GLULISINE (RECOMBINANT DNA ORIGIN)Active
Strength: 100 UNIT / ML
Monograph: INSULIN GLULISINE (RECOMBINANT DNA ORIGIN)